Role of nitric oxide on human Schistosomiasis mansoni: Upregulation of in vitro granuloma formation by Nω-nitro-L-arginine methyl ester

Nitric Oxide - Biology and Chemistry

Volumn 2, Issue 1, 1998, Pages 57-65

  Oliveira, Diana M ^a,b   Silva Teixeira, David N ^a   Carmo, Silvania A ^a   Goes, Alfredo M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Granuloma; Human cells; In vitro; Inflammation; L NAME; Nitric oxide; Schistosoma mansoni

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ARTICLE; CONTROLLED STUDY; GRANULOMA; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 0032004699     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1997.0164     Document Type: Article

References (45)

1. Schimidt H. H. H. W., Hofmann H., Schindler U., Shutenko Z. S., Cunningham D. D., Feelisch M. No NO from NO synthase. Proc. Natl. Acad. Sci. USA. 93:1996;14492-14497.
2. Appleton I., Tomlinson A., Willoughby D. A. Induction of ciclo-oxigenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:1996;27-78.
3. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
4. Sicher S. C., Vazquez M. A., Lu C. Y. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1300.
5. Xie Q., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
6. Kubes P. Polymorphonuclear leukocyte-endothelium interactions: A role for pro-inflammatory and anti-inflammatory molecules. Can. J. Physiol. Pharmacol. 71:1993;88-97.
7. Schimidt H. H. H. W., Walter U. NO at work. Cell. 78:1994;919-925.
8. Hibbs J. B. Jr., Taintor R. R., Vavrin Z., Rachlin E. M. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:1989;87-94.
9. g-nitro-L-arginine. Br. J. Pharmacol. 118:1996;1433-1440.
10. Fukoto J. M., Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: Potential selective inhibition. Annu. Rev. Pharmacol. Toxicol. 35:1995;165-194.
11. Liew F. Y., Li Y., Severn A., Millott S., Schmidt A., Salter M., Moncada S. A possible novel pathway of regulation by murine T helper-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21:1991;2489-2494.
12. Moncada, S. Higgs, E. A. 1993, Biological relevance of theL-arginine:nitric oxide pathway, In, Nitric Oxide: Brain and Immune System, 1, 12, Portland Press, London.
13. Iuvone T., Carnuccio R., Di Rosa M. Modulation of granuloma formation by endogenous nitric oxide. Eur. J. Pharmacol. 265:1994;89-92.
14. Brenner T., Brocke S., Szafer F., Sobel R. A., Parkinson J. F., Perez D. H., Steinman L. J. Immunol. 158:1997;2940-2946.
15. Boros D. L. Immunopathology ofSchistosoma mansoniinfection. Clin. Microbiol. Rev. 2:1989;250-269.
16. Goes A. M., Rezende S. A., Gazzinelli G., Doughty B. L. Granulomatous hypersensitivity toSchistosoma mansoniegg antigens in human schistosomiasis. IV. A role for prostaglandin-induced inhibition ofin vitrogranuloma formation. Parasite Immunol. 16:1994;11-18.
17. Dougthy B. L., Ottesen E. A., Nash T. E., Phillips S. M. Delayed hypersensitivity granuloma formation aroundSchistosoma mansonieggsin vitro.III. Granuloma formation and modulation in human schistosomiasis mansoni. J. Immunol. 133:1984;993-997.
18. Silva-Teixeira D. N., Doughty B. L., Goes A. M. Human schistosomiasis: Modulation ofin vitrogranulomatous hypersensitivity and lymphocyte proliferative response by macrophages undergoing differentiation. Scand. J. Immunol. 44:1996;522-529.
19. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. 14:1972;397-400.
20. Thorsby G., Bratlier A. A rapid method for preparation of pure lymphocyte suspensions. Histocompatibility Testing. 1970;Williams and Wilkins. p. 665-667.
21. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
22. Mukerjee R., Misra A., Chaturvedi U. C. Dengue virus-induced cytotoxin releases nitrite by spleen cells. Int. J. Exp. Pathol. 77:1996;45-51.
23. Oswald I. P., James S. L. Nitrogen oxide in host defense against parasites. Methods. 10:1996;8-14.
24. Saito S., Nakano M. Nitric oxide production by peritoneal macrophages ofMycobacterium bovisBCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines. J. Leukocyte Biol. 59:1996;908-915.
25. Warren K. S., Domingo E. D. Granuloma formation aroundSchistosoma mansoni, S. haematobiumandS. japonicumeggs. Size and rate of development, cellular composition, cross-reactivity and rate of egg destruction. Am. J. Trop. Med. Hyg. 29:1970;292-304.
26. Tood C. W., Goodgame R. M., Colley D. G. Immune response during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J. Immunol. 122:1979;1440-1446.
27. Lima M. S., Gazzinelli G., Nascimento E., Parra J. C., Montesano M. A., Colley D. G. Immune responses during human schistosomiasis mansoni. Evidence for anti-idiotypic T lymphocyte responsiveness. J. Clin. Invest. 78:1986;983-988.
28. Dougthy B. L., Goes A. M., Parra J. C., Rocha R., Cone J. C., Colley D. G., Gazzinelli G. Anti-idiotypic T cells in human schistosomiasis. Immunol. Invest. 18:1989;373-388.
29. Cottrel B. J., Humber D., Sturrock R. F. An immunosuppressive factor in the serum of patients with schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 75:1980;415-416.
30. Rezende S. A., Miranda T. C. L., Ferreira M. G., Goes A. M. In vitrogranuloma modulation by immune complexes in human schistosomiasis mansoni. Braz. J. Med. Biol. Res. 26:1993;207-211.
31. Rezende S. A., Silva-Teixeira D. N., Drummond S. C., Goes A. M. IL-10 plays a role in the modulation of human granulomatous hypersensitivity againstSchistosoma mansonieggs induced by immune complexes. Scand. J. Immunol. 46:1997;96-102.
32. Almeida C. A., Goes A. M. The role of protein kinases in antigen-activation of peripheral blood mononuclear cells ofSchistosoma mansoniinfected individuals. Mem. Inst. Oswaldo Cruz. 92:1997;613-617.
33. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
34. Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., al-Saffar N., Revell P. A., Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am. J. Pathol. 150:1997;881-887.
35. Miller M. J., Chotinaruemol S., Sadowska-Krowicka H., Kakkis J. L., Munshi U. K., Zhang X. J., Clark D. A. Nitric oxide: The "Jekyll and Hyde" of gut inflammation. Agents Actions. 39:1993;C180-C182.
36. Peterson D. A., Peterson D. C., Archer S., Weir E. K. The nonspecificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187:1992;797-801.
37. Granger J. P., Alberola A. M., Salazar F. J., Nakamura T. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J. Cardiovasc. Pharmacol. 20:1992;S160-S162.
38. Kawabata A., Hata T. Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis by environmental stress in the rat. Br. J. Pharmacol. 119:1996;346-350.
39. Szabo C., Bryk R., Zingarelli B., Southan G. J., Gahman T. C., Bhat V., Salzman A. L., Wolff D. J. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br. J. Pharmacol. 118:1996;1659-1668.
40. Adams L. B., Hibbs J. B. Jr., Taintor R. R., Krahenbuhl J. L. Microbiostatic effect of murine-activated macrophages forToxoplasma gondii.Role for synthesis of inorganic nitrogen oxides fromL-arginine. J. Immunol. 144:1990;2725-2729.
41. Kubes P., Suzuki M., Granger D. N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:1991;4651-4655.
42. MacAllister R. J., Parry H., Kimoto M., Ogawa T., Russel R. J., Hodson H., Whitley G. St. J., Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119:1996;1533-1540.
43. Green S. J., Nacy C. A., Schreiber R. D., Granger D. L., Crawford R. M., Meltzer M. S., Fortier A. H. Neutralization of gamma interferon and tumor necrosis factor alpha blocksin vivosynthesis of nitrogen oxides fromL-arginine and protection againstFrancisella tularensisinfection inMycobacterium bovisBCG-treated mice. Infect. Immun. 61:1993;689-698.
44. Evans T. G., Thai L., Granger D. L., Hibbs J. B. Jr. Effect ofin vivoinhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151:1993;907-915.
45. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.